Brian D. Paulson

Silicon Valley
  • 140 Scott Drive
  • Menlo Park, CA 94025
  • USA
 
 

Brian Paulson advises companies and investment banks on capital markets transactions and also advises companies across a wide range of industries on securities compliance, corporate governance, and strategic transactions.

Mr. Paulson regularly advises clients on:

  • Initial public offerings (IPOs)
  • Other public and private debt and equity securities offerings
  • Corporate governance issues
  • Public company disclosure issues
  • Federal and state securities law compliance
  • Strategic transactions

He has particular experience with companies in several industries, including:

  • Internet and digital media
  • Semiconductors
  • Life sciences
  • REITs

Mr. Paulson draws on significant experience representing both issuers and investment banks on debt and equity offerings. He combines an east coast banking sensibility with a west coast focus.

Mr. Paulson’s representative long-standing public company clients include:

  • Advanced Micro Devices
  • Bio-Rad Laboratories
  • Broadcom
  • Redwood Trust
  • Wix

He has more than a decade of experience advising on transactions. Representative significant transactions include advising:

  • The underwriters in the IPO of SurveyMonkey
  • The underwriters in Twilio’s IPO and follow on offering and the initial purchasers in Twilio’s private offering of convertible senior notes
  • The underwriters in the IPO of Arlo Technologies
  • Advanced Micro Devices in multiple private offerings of senior notes and public offerings of convertible senior notes and common stock
  • Redwood Trust in multiple public offerings of common stock and convertible senior notes
  • Cree in a private offering of convertible senior notes
  • Wix.com in a private offering of convertible senior notes
  • The underwriters in Angie’s List’s IPO and follow-on offering
  • The underwriters in the IPO for Ruckus Wireless
  • The underwriters in WageWorks’ IPO and multiple follow-on offerings
  • The underwriters in the IPO of Odonate Therapeutics
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.